Coronary Circulation and Plastic Contamination
The presence of micro and nanoplastics (MNPs) in the human body is no longer a theoretical concern but a documented clinical reality. Recent analysis of the coronary circulation-the blood supply directly feeding the heart-indicates a significant correlation between the presence of these particles and acute cardiovascular events.
Research conducted through a collaboration between Sapienza University of Rome, the University of Verona, and the Research Centre on Environmental Pollution and Cardiovascular Diseases at the University of Campania “Luigi Vanvitelli” has identified elevated levels of plastics in patients who have suffered serious heart attacks.
Dr Pasquale Paolisso from Sant’Andrea Hospital Sapienza University of Rome, Italy, noted: “Micro and nanoplastics are tiny plastic particles that are found virtually everywhere in the environment, including the air we breathe, the water we drink, and many foods we consume. In recent years, scientists have begun to detect these particles in human tissues and organs, raising concerns about their potential health effects”.
The investigation specifically sought to determine if these particles accumulate in the arteries of the heart and whether lifestyle or environmental factors influence this accumulation. Dr Paolisso added: “However, very little was known about whether these particles are present in the coronary circulation – the blood flowing through the arteries that supply the heart – or whether environmental exposures such as smoking and air pollution might influence their presence.”
Plastic Prevalence by Patient Condition
To test those questions in a real‑world clinical setting, the study analyzed blood samples from 61 patients undergoing coronary angiography, comparing those with acute heart attacks against those with chronic ischemic heart disease and a control group with normal coronary arteries. The most frequently detected material was polyethylene, a plastic widely utilized in global packaging and consumer goods.
| Patient Category | Detection Rate of Micro/Nanoplastics |
|---|---|
| Heart Attack Patients | 84% |
| Chronic Ischemic Heart Disease | 40% |
| Normal Coronary Arteries | 32% |
These detection rates mirror a broader understanding of coronary artery disease as a process driven not only by cholesterol and blood pressure, but also by chronic damage to the vessel wall. In coronary artery disease, fatty deposits and inflammatory cells gradually narrow or block the arteries that supply blood to the heart muscle, increasing the risk of heart attack and sudden death.[3] The emerging concern is that plastic fragments circulating in the blood may become an additional, and previously uncounted, stressor on already vulnerable vessels.
Environmental Triggers and Inhalation Risks
The data suggests a strong link between the inhalation of pollutants and the systemic presence of plastics. The respiratory system may act as a primary gateway, allowing microscopic particles to bypass natural filters and enter the bloodstream.
The risk factors identified include:
- Tobacco Use: Smokers were found to be six times more likely to have microplastics in their blood.
- Atmospheric Pollution: Long-term exposure to air pollution, specifically particles measuring 2.5 μm or less (PM2.5), increased the likelihood of MNP detection.
- Compound Exposure: 100% of patients who both smoked and lived in high-pollution areas had plastics in their blood, compared to only 12.5% of non-smokers in low-pollution environments.
Professor Emanuele Barbato, Director of the Cardiology Unit of Sant’Andrea University Hospital, clarified the relationship: “These findings do not prove that microplastics cause heart attacks, but they reveal a strong association between environmental exposures, microplastics in the blood and cardiovascular disease.”
Regarding the mechanism of entry, Professor Barbato stated: “In our study, smoking history was strongly linked to microplastics in the blood. Our findings suggest that smoking might make it easier for micro and nanoplastics to enter the blood stream via the lungs. Air pollution may act in a similar way.”
These observations place plastic exposure alongside already regulated air pollutants such as PM2.5, which are monitored and limited under frameworks like the European Union’s ambient air quality standards, and give cardiovascular specialists a concrete environmental signal to watch as governments revisit clean‑air rules.
Systemic Inflammation and Vascular Injury
The clinical implications extend beyond the mere presence of particles. The accumulation of MNPs is associated with biochemical markers of inflammation, which are known drivers of cardiovascular disease. Inflammation contributes to the formation and destabilization of atherosclerotic plaques-the fatty, fibrous buildups that narrow arteries and can suddenly rupture, triggering heart attacks or strokes.[1]
Professor Andreas Daiber from University Medical Centre of the Johannes Gutenberg University observed: “Over time, plastics fragment into microplastics (<5 mm) and nanoplastics (<1 μm), which are now detected in virtually all environmental compartments, including air, water, and soil. Increasingly, these particles are also found within the human body, including blood, lung tissue, placenta, and breast milk, indicating systemic exposure.”
Professor Daiber further detailed the clinical observations: “Until recently, the cardiovascular effects of plastic exposure were largely speculative. However, emerging clinical evidence now suggests a potential link between NMPs and cardiovascular disease. In patients undergoing carotid endarterectomy, NMPs were detected within atherosclerotic plaques, and their presence was associated with an increased risk of myocardial infarction, stroke, and all-cause mortality. In their study published in this issue of the European Heart Journal, Paolisso et al. investigated 61 patients undergoing coronary angiography for suspected coronary artery disease. Patients were categorized into ST-segment elevation myocardial infarction (STEMI), chronic coronary syndromes (CCS), and controls. Using advanced analytical methods, NMPs were detected in both peripheral and coronary blood. Notably, plastic particle concentrations were highest in STEMI patients, intermediate in those with CCS, and lowest in controls. These findings were accompanied by elevated inflammatory markers, including tumour necrosis factor-α and interleukin-6, suggesting a link between plastic exposure and systemic inflammation. Although limited by sample size, these findings represent early clinical evidence that plastic particles may be associated with acute cardiovascular events.”
Public Health and Regulatory Imperatives
The emergence of MNPs as a potential cardiovascular risk factor suggests that traditional medical models focusing solely on diet and genetics may be incomplete. The concept of the “exposome”-the measure of all the exposures of an individual in a lifetime and how those exposures relate to health-is becoming central to medical policy and risk assessment.
For public authorities, the findings arrive as regulators are already under pressure to tighten air quality and plastic‑waste rules. Existing environmental and health frameworks, from national clean‑air acts to global agreements on plastic pollution, have tended to treat cardiovascular disease and plastic exposure as separate policy silos. The coronary evidence reported here challenges that separation and points to a shared policy frontier where cardiology and environmental regulation overlap.
Professor Barbato emphasized the necessity of a systemic response: “The results highlight the need to consider microplastic pollution as part of the broader environmental determinants of health. Policies that reduce air pollution, tobacco exposure and environmental plastic contamination could have benefits that extend beyond environmental protection and potentially improve cardiovascular health.”
This shift requires a coordinated approach between healthcare providers, environmental regulators and legislators to mitigate population-level risks-ranging from integrating cardiovascular endpoints into air quality rule‑making, to strengthening surveillance of occupational and urban exposures, to ensuring that clinical guidelines begin to reflect environmental risk where evidence is sufficient.
Professor Daiber concluded: “NMPs represent a rapidly emerging environmental exposure with potentially important implications for cardiovascular health. Early clinical evidence demonstrates that plastic particles can enter the circulation and accumulate in vascular tissues, while experimental studies indicate that they trigger key mechanisms of vascular injury, including oxidative stress, inflammation, and endothelial dysfunction. Although substantial uncertainties remain, the convergence of epidemiological, clinical, and mechanistic evidence suggests that plastic pollution may represent a previously underestimated cardiovascular risk factor. Addressing this challenge will require coordinated efforts across disciplines and policy domains. In the era of the Anthropocene, protecting cardiovascular health will increasingly depend on reducing not only traditional risk factors but also the growing burden of environmental pollutants (the detrimental part of the exposome), among which plastics may soon play a central role.”
Related reading
